Thread by @ACHEST1

"Africa should join #COVAX not just a beneficiary but as a contributor of the best science and financial resources," ✍️ Prof. @FrancisOmaswa in his @newvisionwire op-ed today

#COVID19Vaccine
#PressDigest

Here is the link to the article by Prof. @FrancisOmaswa on the Global Scramble for COVID-19 vaccines, and what this means for Africa. achest.org/index.php?opti…

We must call upon Africa to mount an effective response now and prepare for the future pandemics by developing internal capacity to develop, manufacture and distribute vaccines, diagnostics and therapeutics within the continent in partnership with the rest of the world.

"Africa should join COVAX not just as a beneficiary but as a contributor of the best science and financial resources," says Prof. Francis Omaswa

. Prof. @MiriamKWere says this article on the scramble for COVID-19 Vaccines achest.org/index.php?opti… is " informative on the challenges that are posed in the current& future of outbreaks anywhere in the world.
"I join your call for Africa to take note and initiate action."

. @KADAMAP: "This is an important matter to de-link from panic by our policy maker and their technical advisors. achest.org/index.php?opti…

"A strong informed voice from the region is required for an equitable outcome by ensuring as you rightly make the call that "Africa should join #COVAX not just as a beneficiary but as a contributor of the best science and financial resources." says Dr. @kadamap

A discourse btw'n the EU&big-Pharma corporates have proposed to reschedule contracted supply commitments to the EU by cutting this down by 60%. This has surprisingly elicited an interesting reaction from the UK refusing to disclose their contracted agreement with the big-Pharma

"This lack of transparency in this discourse, at that level, is unfortunate for the #COVAX facility; especially if, Covax beneficiary member states are to interface directly with big-Pharma for access to vaccine products under "Emergency Use" legal frameworks," says @kadamap

"Engagement with commercial entities during product developmental stages require the utmost caution to considerations of all benefits and liabilities of final products after the emergency phase," -- @kadamap

The panic and scramble descried in this article achest.org/index.php?opti…, is obstructing the visibility of the lack of transparency of this product development which in the long run may be borne by the least informed -- @kadamap

. #AU & @WHO need to mitigate this by negotiating on an informed basis, the most equitable contractual arrangements for Africa in particular to access these COVID-19 trial vaccines for "Emergency Use," prior to commercial marketing as full partners not just donation recipients.

"The involvement of our population is an invaluable investment in the product development and possibly equity in the final product value," @kadamap achest.org/index.php?opti…

@threadreaderapp unroll